אוקסיקונטין 20
rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 20 mg - oxycodone - oxycodone - for the relief of moderate severe chronic pain.
אוקסיקונטין 10
rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 10 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.
אוקסיקונטין 80
rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 80 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.
אוקסיקונטין 40
rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 40 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.
אוקסיקוד 2 מגמל סירופ
rafa laboratories ltd - oxycodone hydrochloride - סירופ - oxycodone hydrochloride 10 mg / 5 ml - oxycodone - oxycodone - for use in the relief of moderate to severe pain.
אוקסיקוד פורטה 10 מגמל סירופ
rafa laboratories ltd - oxycodone hydrochloride - סירופ - oxycodone hydrochloride 10 mg/ml - oxycodone - oxycodone - for the relief of moderate to severe pain.
אוקסיקונטין 5 מג
rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.
אוקסיקונטין 5 מג
rafa laboratories ltd - oxycodone hydrochloride - טבליות בשחרור מבוקר - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.
אקטוס 15 מג
tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 15 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi
אקטוס 30 מג
tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 30 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi